Zoetis stock plummeted Thursday, undercutting its 50-day line, after the animal health player missed guidance expectations for 2025. For the year, the company expects to earn an adjusted $6 to $6. ...

Zoetis (ZTS) closed at $170.37 in the latest trading session, marking a +1.87% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.55%. At the same time, the Dow added 0.52% ...

Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in ...

Zoetis (ZTS) closed the most recent trading day at $163.03, moving -0.08% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.08%. At the same time ...

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...

Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more. Appeals court rejects Trump's emergency bid to curtail birthright citizenship ...